Consumer Updates
The FDA's Center for Biologics Evaluation and Research (CBER) issued updated consumer-focused health and safety information intended to provide science-based guidance.
The information affects manufacturers and stakeholders involved in biologics, as well as functions responsible for monitoring regulatory communications and safety signals.
This update serves as a channel for disseminating technical and safety signals that may impact post-market surveillance or internal risk assessments. While the source provided is sparse on granular detail, these updates often precede or accompany formal regulatory shifts or labeling requirements for biological products.
Regulatory and compliance teams should monitor this FDA publication channel for technical updates and safety information relevant to biological products. Personnel responsible for information dissemination should ensure these updates are reviewed as part of routine surveillance.
Science-based health and safety information you can trust.
Open in openFDA / FDA.gov